# Esperion Therapeutics Inc. (ESPR) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2025 | -$23M |
| 2024 | -$52M |
| 2023 | -$209M |
| 2022 | -$234M |
| 2021 | -$269M |
| 2020 | -$144M |
| 2019 | -$97M |
| 2018 | -$202M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2026-03-31 | -$25M |
| 2025-09-30 | -$31M |
| 2025-06-30 | -$13M |
| 2025-03-31 | -$40M |
| 2024-09-30 | -$30M |
| 2024-06-30 | -$62M |
| 2024-03-31 | $61M |
| 2023-09-30 | -$41M |
| 2023-06-30 | -$50M |
| 2023-03-31 | -$62M |
| 2022-09-30 | -$55M |
| 2022-06-30 | -$66M |
| 2022-03-31 | -$57M |
| 2021-09-30 | -$69M |
| 2021-06-30 | -$44M |
| 2021-03-31 | -$91M |
| 2020-09-30 | -$85M |
| 2020-06-30 | $125M |
| 2020-03-31 | -$78M |
| 2019-09-30 | -$68M |
| 2019-06-30 | -$54M |
| 2019-03-31 | $87M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ESPR/net-income)